Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (611-620 of 745) with videos related to

Pageof 75
Sort By:
Bioinformatics (Oxford, England)|October 3, 2017
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysisJochen Singer, Hans-Joachim Ruscheweyh, Ariane L Hofmann, et al.
EMBO Molecular Medicine|June 14, 2017
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureMichael P Smith, Emily J Rowling, Zsofia Miskolczi, et al.
Journal of Translational Medicine|July 23, 2018
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy)Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.
The Journal of Investigative Dermatology|September 17, 2010
Primary cutaneous CD30+ anaplastic large-cell lymphomas show a heterogeneous genomic profile: an oligonucleotide arrayCGH approachJúlia M Sánchez-Schmidt, Rocío Salgado, Octavio Servitje, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Health-related quality of life results from the phase III CheckMate 067 studyDirk Schadendorf, James Larkin, Jedd Wolchok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 PatientsTakami Sato, Marcus O Butler, Sophie Piperno-Neumann, et al.
Nature Medicine|January 8, 2025
Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trialReinhard Dummer, Caroline Robert, Richard A Scolyer, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2019
Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)Celeste Lebbe, Claus Garbe, Alexander J Stratigos, et al.
The Lancet. Oncology|May 19, 2015
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trialMichael R Migden, Alexander Guminski, Ralf Gutzmer, et al.
Molecular Cancer Research : MCR|June 24, 2020
SPANX Control of Lamin A/C Modulates Nuclear Architecture and Promotes Melanoma GrowthIkrame Lazar, Bertrand Fabre, Yongmei Feng, et al.
Pageof 75

Showing results (611-620 of 745) with videos related to

Sort By:
Pageof 75
Bioinformatics (Oxford, England)|October 3, 2017
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysisJochen Singer, Hans-Joachim Ruscheweyh, Ariane L Hofmann, et al.
EMBO Molecular Medicine|June 14, 2017
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureMichael P Smith, Emily J Rowling, Zsofia Miskolczi, et al.
Journal of Translational Medicine|July 23, 2018
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy)Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.
The Journal of Investigative Dermatology|September 17, 2010
Primary cutaneous CD30+ anaplastic large-cell lymphomas show a heterogeneous genomic profile: an oligonucleotide arrayCGH approachJúlia M Sánchez-Schmidt, Rocío Salgado, Octavio Servitje, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Health-related quality of life results from the phase III CheckMate 067 studyDirk Schadendorf, James Larkin, Jedd Wolchok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 PatientsTakami Sato, Marcus O Butler, Sophie Piperno-Neumann, et al.
Nature Medicine|January 8, 2025
Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trialReinhard Dummer, Caroline Robert, Richard A Scolyer, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2019
Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)Celeste Lebbe, Claus Garbe, Alexander J Stratigos, et al.
The Lancet. Oncology|May 19, 2015
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trialMichael R Migden, Alexander Guminski, Ralf Gutzmer, et al.
Molecular Cancer Research : MCR|June 24, 2020
SPANX Control of Lamin A/C Modulates Nuclear Architecture and Promotes Melanoma GrowthIkrame Lazar, Bertrand Fabre, Yongmei Feng, et al.
Pageof 75